Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1454 ARTÍCULOS , VIENDO DEL 286 AL 300

Understanding the cause of sporadic Alzheimer's disease

Zetterberg H, Mattsson N.

Expert Rev Neurother. 2014 Jun;14(6):621-30. doi: 10.1586/14737175.2014.915740.

A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease

Karran E, Hardy J.

Ann Neurol. 2014 Aug;76(2):185-205. doi: 10.1002/ana.24188. Epub 2014 Jul 2.

The intersection of amyloid beta and tau at synapses in Alzheimer's disease

Spires-Jones TL, Hyman BT.

Neuron. 2014 May 21;82(4):756-71. doi: 10.1016/j.neuron.2014.05.004.

The amyloid state and its association with protein misfolding diseases

Knowles TP, Vendruscolo M, Dobson CM.

Nat Rev Mol Cell Biol. 2014 Jun;15(6):384-96. doi: 10.1038/nrm3810.

The pancreas-brain axis: insight into disrupted mechanisms associating type 2 diabetes and Alzheimer's disease

Desai GS, Zheng C, Geetha T, Mathews ST, White BD, Huggins KW, Zizza CA, Broderick TL, Babu JR.

J Alzheimers Dis. 2014;42(2):347-56. doi: 10.3233/JAD-140018.

Increased O-GlcNAc levels correlate with decreased O-GlcNAcase levels in Alzheimer disease brain

Förster S, Welleford AS, Triplett JC, Sultana R, Schmitz B, Butterfield DA.

Biochim Biophys Acta. 2014 Sep;1842(9):1333-9. doi: 10.1016/j.bbadis.2014.05.014. Epub 2014 May 23.

Dysfunctional Wnt/β-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer's disease

Liu L, Wan W, Xia S, Kalionis B, Li Y.

Neurochem Int. 2014 Sep;75:19-25. doi: 10.1016/j.neuint.2014.05.004. Epub 2014 May 22.

Dopaminergic modulation of cortical plasticity in Alzheimer's disease patients

Koch G, Di Lorenzo F, Bonnì S, Giacobbe V, Bozzali M, Caltagirone C, Martorana A.

Neuropsychopharmacology. 2014 Oct;39(11):2654-61. doi: 10.1038/npp.2014.119. Epub 2014 May 26.

Which rivastigmine formula is better for heart in elderly patients with Alzheimer's disease: oral or patch?

Isik AT, Soysal P, Yay A.

Am J Alzheimers Dis Other Demen. 2014 Dec;29(8):735-8. doi: 10.1177/1533317514536598. Epub 2014 May 26.

[Effects of a neuropsychology program based on mindfulness on Alzheimer's disease: randomized double-blind clinical study]

Quintana Hernández DJ, Miró Barrachina MT, Ibáñez Fernández I, del Pino AS, García Rodríguez Jr, Hernández JR.

Rev Esp Geriatr Gerontol. 2014 Jul-Aug;49(4):165-72. doi: 10.1016/j.regg.2014.03.002. Epub 2014 May 28.

Therapeutic benefits of H₂S in Alzheimer's disease

Wei HJ, Li X, Tang XQ.

J Clin Neurosci. 2014 Oct;21(10):1665-9. doi: 10.1016/j.jocn.2014.01.006. Epub 2014 Jun 2.

The role of Wnt signaling in the development of Alzheimer's disease: a potential therapeutic target?

Wan W, Xia S, Kalionis B, Liu L, Li Y.

Biomed Res Int. 2014;2014:301575. doi: 10.1155/2014/301575. Epub 2014 May 4.

Probable novel PSEN2 Val214Leu mutation in Alzheimer's disease supported by structural prediction

Youn YC, Bagyinszky E, Kim H, Choi BO, An SS, Kim S.

BMC Neurol. 2014 May 15;14:105. doi: 10.1186/1471-2377-14-105.

[The cost of applying the Dependency Law to Alzheimer disease]

Soto-Gordoa M, Arrospide A, Zapiain A, Aiarza A, Abecia LC, Mar J.

Gac Sanit. 2014 Sep-Oct;28(5):389-92. doi: 10.1016/j.gaceta.2014.04.012. Epub 2014 Jun 2.

The normal and pathologic roles of the Alzheimer's β-secretase, BACE1

Kandalepas PC, Vassar R.

Curr Alzheimer Res. 2014;11(5):441-9. doi: 10.2174/1567205011666140604122059.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias